AB-19

N/A

Report date: 2024/08/01 17:45:59
NME

Base Information

Drug NameAB-19
Drug Alias NameAB-19
ClassificationSmall molecules
Mechanisms of ActionNADPH oxidase modulators
TargetsNADPH oxidase
Therapy Area/IndicationsSolid tumoursWet age-related macular degenerationHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAptabio Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAptabio Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursWet age-related macular degenerationHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A